Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02085980 · ClinicalTrials.gov registry record · NA
Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy
A NA study of Vulvovaginal Atrophy, sponsored by El. En. SpA.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT02085980 is a NA study of Vulvovaginal Atrophy that has completed, run by El. En. SpA. The registered enrollment target is 30 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02085980, a NA study of Vulvovaginal Atrophy, has completed, sponsored by El. En. SpA.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the safety and the efficacy of a laser in the treatment of vulvovaginal atrophy (VVA), that is to assess the change in the severity of the vaginal dryness symptom, by means of a visual analogic scale (10 cm VAS).
Conditions Studied
Interventions
- DEVICE Laser treatment
Study Locations (2)
California
- Stanford University - Palo Alto
Ohio
- The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital - West Chester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02085980
The ClinicalTrials.gov registry entry for NCT02085980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is El. En. SpA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vulvovaginal Atrophy appearing as the primary indexed condition, and to 1 intervention - of which Laser treatment is the first listed.
NCT02085980 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Ohio.
Frequently Asked Questions
What is clinical trial NCT02085980 about?
NCT02085980 is a clinical study titled "Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy". The purpose of this study is to assess the safety and the efficacy of a laser in the treatment of vulvovaginal atrophy (VVA), that is to assess the change in the severity of the vaginal dryness symptom, by means of a visual analogic scale (10 cm VAS).
What is the current status of trial NCT02085980?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-03. Estimated completion is 2015-11.
What conditions does trial NCT02085980 study?
This clinical trial studies the following conditions: Vulvovaginal Atrophy.
What interventions are being tested in trial NCT02085980?
The interventions under investigation include: Laser treatment (DEVICE).
Who is sponsoring clinical trial NCT02085980?
This trial is sponsored by El. En. SpA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02085980 being conducted?
This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vulvovaginal Atrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.